Clinical Trials Directory

Trials / Completed

CompletedNCT03992859

Continuous Serrates Plane Block in Axillary Dissection

Continuous Serratus Plane Block Added to PECS II vs PECS II Alone for Post Operative Analgesia After Axillary Dissection in Breast Cancer Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Azienda USL Reggio Emilia - IRCCS · Other Government
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Patients undergone to axillary dissection during breast surgery with a PECS I, II block will be randomized to receive either a serratus plane continuous local anesthetic infusion through a multiple hole catheter or nothing. Both groups will receive a patient controlled analgesia with morphine.

Detailed description

84 patients ASA I-III undergoing breast surgery with axillary dissection after modified PECS II block as described by Blanco et al. with Ropivacaine 0.37% 30 ml. General anesthesia with remifentanil 0.1 mcg/Kg/min and Propofol 1.5-2 mg/Kg to facilitate endotracheal intubation will provide for all patients, and maintained with Desflurane and Remifentanil infusion. In case of axillary dissection patient will be randomized to receive either a serratus plane continuous local anesthetic infusion through a multiple hole catheter or nothing. Both groups will receive as intraoperative analgesia 1 g Acetaminophene ev 30 minute before the end of the surgery and 1g. 8h-1 postoperative associated to a patient controlled analgesia with morphine. PCA will set up as follow: bolus 1 mg, lock-out 6 minute, max 20 mg/4h. In the serratus group 10 ml of Ropivacaine 0.5% before fascial closure and a continuous infusion of 12 ml/h of Ropivacaine 0.2% will be provide.

Conditions

Interventions

TypeNameDescription
PROCEDUREContinuous serratus plane blockPeripheral nerve catheter placed by the surgeon at the end of surgery

Timeline

Start date
2018-01-12
Primary completion
2019-11-13
Completion
2021-12-30
First posted
2019-06-20
Last updated
2025-06-25

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03992859. Inclusion in this directory is not an endorsement.